SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-474715
Filing Date
2016-02-24
Accepted
2016-02-24 09:08:35
Documents
3
Period of Report
2016-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d246501d8k.htm 8-K 22577
2 EX-99.1 d246501dex991.htm EX-99.1 12823
3 GRAPHIC g246501img001.jpg GRAPHIC 8753
  Complete submission text file 0001193125-16-474715.txt   48662
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51820 | Film No.: 161450619
SIC: 2834 Pharmaceutical Preparations